Your browser doesn't support javascript.
loading
Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma.
Li, Chao-Jen; Tsai, Hung-Wen; Chen, Yi-Li; Wang, Chun-I; Lin, Yang-Hsiang; Chu, Pei-Ming; Chi, Hsiang-Cheng; Huang, Yi-Ching; Chen, Cheng-Yi.
Afiliação
  • Li CJ; Department of General & Gastroenterological Surgery, An Nan Hospital, China Medical University, Tainan, Taiwan.
  • Tsai HW; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Chen YL; Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Wang CI; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • Lin YH; Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chu PM; Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Chi HC; Department of Medical Education, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Huang YC; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
  • Chen CY; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan.
J Hepatocell Carcinoma ; 10: 123-138, 2023.
Article em En | MEDLINE | ID: mdl-36741246

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: J Hepatocell Carcinoma Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: J Hepatocell Carcinoma Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan